Centurium Capital Closes Its Debut Dollar Fund at Over US$2 Billion

Beijing, China, July 3, 2019 – Centurium Capital, a leading private equity firm in China, today announced the successful close of its debut US dollar fund, Centurium Capital Partners 2018 L.P. at over US$2 billion, far exceeding its target size. The fund has secured overwhelming interests from global institutional investors including pension funds, sovereign wealth funds, family offices, corporate pensions, FOFs, and other financial institutions. The fund was launched in March 2018 and reached a significant first close of nearly US$1 billion in June 2018.

Centurium Capital primarily focuses on investing into China’s consumer, services and healthcare sectors. The firm’s investment theses are built around its core investment strategy of “invest to transform”. Centurium seeks to invest in control or significant minority private equity stakes with a particular focus on in-depth engagement to improve operational efficiency and solve structural deficiencies.

David Li, Chairman and CEO of Centurium Capital, commented, “The successful fundraise is a vote of confidence in China’s long term growth potential by global investors, as well as a strong testament to our firm’s strategy and ability of investing to transform. In the context of China’s new norm of economic growth model and fast-evolving business landscape, Chinese companies and entrepreneurs are faced with unprecedented new challenges as well as new opportunities. With a unique combination of global best practice and local expertise and experience, Centurium Capital is well positioned to provide bespoke solutions to these challenges and opportunities by being a long term partner of capital and mindshare to our portfolio companies and entrepreneurs”.

Since its first close, Centurium Capital has made a number of investments, including Luckin Coffee (NASDAQ: LK), a leading internet based on demand coffee brand and retail chain in China, China Biologic Products (NASDAQ: CBPO), one of the largest plasma-based biopharmaceutical companies in China, and LOHO, China’s leading fast-fashion eyewear brand and retailer with a vertically integrated supply chain.

Sinotau Pharmaceutical

Sinotau Pharmaceutical is an innovative pharmaceutical company focusing on the R&D, production and clinical application of a new generation of radiopharmaceuticals. Headquartered in Beijing, the company has set up radiopharmaceutical production bases in Jiangsu, Guangdong and Sichuan, and branches in the United States. Leveraging the world’s leading R&D resources in the field of radiopharmaceuticals and precision diagnosis and treatment, Sinotau has taken the lead in deploying a variety of targeted therapies and precision diagnostic radiopharmaceuticals in the fields of tumors, neurodegenerative diseases and cardiovascular diseases. The company’s pipeline has deployed multiple radiological diagnostic and therapeutic products, some of which have entered the stage of registered clinical research.

Yigoli

Yigoli is China’s first and leading AI-enabled high-tech car wash solution provider with over 3,000 car wash outlets covering most provinces in China, South Korea, Thailand and Indonesia. Leveraging its self-developed intelligent operation system, Yigoli offers one of the most efficient and environmentally- friendly car wash services for customers in China and abroad.

Yunxuetang

Yunxuetang is a leading corporate training SaaS and services provider in China. Founded in 2011, Yunxuetang provides one-stop training solutions including SaaS, content development and services to thousands of big corporate clients and nearly 30,000 SMEs, including Fortune 500 companies, Tongrentang, Haidilao, Didi, Luckin Coffee and NIO. Headquartered in Beijing and Suzhou, the company has branch offices in over 20 Chinese cities including Shenzhen and Hangzhou.

Yunxuetang’s total solutions include training infrastructure establishment, training materials development, training program maintenance, data analysis and vendor management to meet increasing demands for more efficient staff training as Chinese companies grow and evolve.